Christopher A. Klebanoff, MD

Christopher Klebanoff, MD, is a medical oncologist and translational researcher whose focus is on providing the best care possible to people with breast cancer. He studies T-cell immunobiology with an emphasis on adoptive T-cell immunotherapy for the treatment of solid malignancies. His dual role in the clinical setting and the laboratory allows him to work with patients to develop more-effective, less-toxic therapies.

• 2000: Emory University, BS, Chemistry
• 2006: Emory University School of Medicine, MD

• 2019: Brain Tumor Funders’ Collaborative Grant
• 2013: NIH Fellows Award for Research Excellence
• 2011: NCI/Center for Cancer Research Post Doctoral Research Fellow of the Year
• 2006: AOA National Medical Honor Society
• 2004: Howard Hughes Medical Institute continuing support scholarship
• 2000: Merck Index Award